Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | DPP4 | P27487 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1219412 | 0.84 | ALDH1A1 (0.52) | DPP4ALDH1A1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL13570397 | 0.80 | DPP4 (0.49) | DPP4NPC1HSD11B1FKBP1APOLB | |
| SCHEMBL30874840 | 0.80 | DPP4 (0.49) | DPP4NPC1HSD11B1FKBP1APOLB | |
| SCHEMBL6273381 | 0.77 | MEN1 (0.53) | RAB9ANPC1 | |
| SCHEMBL7469565 | 0.75 | ALDH1A1 (0.52) | DPP4ALDH1A1SMN1; SMN2NPC1FKBP1A | |
| SCHEMBL26616464 | 0.74 | FKBP1A (0.45) | DPP4FKBP1A | |
| SCHEMBL26616469 | 0.74 | FKBP1A (0.45) | DPP4FKBP1A | |
| SCHEMBL4598287 | 0.74 | ALOX5AP (0.60) | ALDH1A1RAB9ASMN1; SMN2NPC1HSD11B1 | |
| SCHEMBL7853026 | 0.73 | ALDH1A1 (0.44) | CASP3DPP4ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL7844655 | 0.73 | CNR1 (0.48) | DPP4ALDH1A1RAB9ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1608369-A2 | USE OF ORGANIC COMPOUNDS FOR IMMUNOPOTENTIATION | CHIRON CORPORATION (US) | 2005-12-28 | — | — | EP | claimed |
| WO-2004087153-A2 | USE OF ORGANIC COMPOUNDS FOR IMMUNOPOTENTIATION | CHIRON CORPORATION (US) | 2004-10-14 | — | — | WO | claimed |